Use of prednisone prior to SARS-CoV-2 diagnosis may be linked to a higher risk of severe COVID-19 outcomes such as hospitalization, intensive care unit (ICU) admission, and death, according to a retrospective community-based study.
An analysis of patients with moderately to severely active ulcerative colitis (UC) highlighted the general safety of the oral sphingosine-1-phosphate (S1P) receptor 1 and 5 modulator ozanimod, according to a presentation at Digestive Disease Week 2021.
Spore-forming probiotics, otherwise termed “sporebiotics”, may help reduce post-prandial gastrointestinal (GI) symptoms such as bloating and epigastric pain in individuals with functional dyspepsia (FD), says an expert at DDW 2021.
Once-weekly injection of the GLP-1* agonist semaglutide, on top of endoscopic sleeve gastroplasty (ESG), led to a greater weight loss and better glucose control vs ESG alone in patients with diabetes and excess weight but are not candidates for bariatric surgery, a new study has shown.
In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.